The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro

Fertil Steril. 1995 Nov;64(5):972-6.

Abstract

Objectives: To examine the effect of equimolar concentrations of hCG and dissociated alpha-subunit on PRL production by leiomyoma and myometrial tissue obtained from different hormonal states and to examine changes in PRL messenger RNA levels as PRL protein levels increased.

Design: Explant cultures of leiomyomas and myometrium were established and cultured for 96 hours. Tissue was studied from normal cycling women, postmenopausal women, pregnant women, and women undergoing GnRH agonist (GnRH-a) therapy. Cultured medium was collected at 24, 48, and 96 hours and assayed for PRL. In selected experiments, tissue was processed at 0 and 96 hours to analyze messenger RNA (mRNA) levels.

Results: Human chorionic gonadotropin and alpha-subunit stimulated PRL secretion in [1] explant cultures of leiomyoma and myometrium from premenopausal women, [2] cultures of tissue treated in vivo with leuprolide acetate for both leiomyoma and myometrium, and [3] myometrium obtained from postmenopausal women. Postmenopausal myometrium was significantly more responsive to stimulation. Prolactin mRNA levels were documented to increase after hormone treatment in postmenopausal myometrium.

Conclusion: Myometrium from postmenopausal women is very responsive to hCG and alpha-subunit. There is a difference in response between tissue obtained from menopausal women and that from women undergoing GnRH-a therapy to achieve a "medical menopause" and reproductive age women. The level of endogenous gonadotropins as well as the steroid milieu may modulate myometrial PRL secretion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Blotting, Northern
  • Chorionic Gonadotropin / pharmacology*
  • Culture Techniques
  • Female
  • Glycoprotein Hormones, alpha Subunit / pharmacology*
  • Gonadotropin-Releasing Hormone / agonists
  • Humans
  • Leiomyoma / chemistry
  • Leiomyoma / drug therapy
  • Leiomyoma / metabolism
  • Leuprolide / pharmacology
  • Leuprolide / therapeutic use
  • Myometrium / chemistry
  • Myometrium / drug effects
  • Myometrium / metabolism*
  • Postmenopause / metabolism*
  • Pregnancy
  • Prolactin / analysis
  • Prolactin / genetics
  • Prolactin / metabolism*
  • RNA, Messenger / analysis
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Radioimmunoassay
  • Time Factors
  • Uterine Neoplasms / chemistry
  • Uterine Neoplasms / drug therapy
  • Uterine Neoplasms / metabolism

Substances

  • Antineoplastic Agents, Hormonal
  • Chorionic Gonadotropin
  • Glycoprotein Hormones, alpha Subunit
  • RNA, Messenger
  • Gonadotropin-Releasing Hormone
  • Prolactin
  • Leuprolide